2024-04-012025-03-312025-03-31false05965639J.A. CRESCENT DENTAL CARE LIMITED2025-12-22falseiso4217:GBPxbrli:pure059656392024-03-31059656392025-03-31059656392024-04-012025-03-31059656392023-03-31059656392024-03-31059656392023-04-012024-03-3105965639bus:SmallEntities2024-04-012025-03-3105965639bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3105965639bus:FullAccounts2024-04-012025-03-3105965639bus:PrivateLimitedCompanyLtd2024-04-012025-03-3105965639core:WithinOneYear2025-03-3105965639core:AfterOneYear2025-03-3105965639core:WithinOneYear2024-03-3105965639core:AfterOneYear2024-03-3105965639core:ShareCapital2025-03-3105965639core:SharePremium2025-03-3105965639core:RevaluationReserve2025-03-3105965639core:OtherReservesSubtotal2025-03-3105965639core:RetainedEarningsAccumulatedLosses2025-03-3105965639core:ShareCapital2024-03-3105965639core:SharePremium2024-03-3105965639core:RevaluationReserve2024-03-3105965639core:OtherReservesSubtotal2024-03-3105965639core:RetainedEarningsAccumulatedLosses2024-03-3105965639core:LandBuildings2025-03-3105965639core:PlantMachinery2025-03-3105965639core:Vehicles2025-03-3105965639core:FurnitureFittings2025-03-3105965639core:OfficeEquipment2025-03-3105965639core:NetGoodwill2025-03-3105965639core:IntangibleAssetsOtherThanGoodwill2025-03-3105965639core:ListedExchangeTraded2025-03-3105965639core:UnlistedNon-exchangeTraded2025-03-3105965639core:LandBuildings2024-03-3105965639core:PlantMachinery2024-03-3105965639core:Vehicles2024-03-3105965639core:FurnitureFittings2024-03-3105965639core:OfficeEquipment2024-03-3105965639core:NetGoodwill2024-03-3105965639core:IntangibleAssetsOtherThanGoodwill2024-03-3105965639core:ListedExchangeTraded2024-03-3105965639core:UnlistedNon-exchangeTraded2024-03-3105965639core:LandBuildings2024-04-012025-03-3105965639core:PlantMachinery2024-04-012025-03-3105965639core:Vehicles2024-04-012025-03-3105965639core:FurnitureFittings2024-04-012025-03-3105965639core:OfficeEquipment2024-04-012025-03-3105965639core:NetGoodwill2024-04-012025-03-3105965639core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105965639core:ListedExchangeTraded2024-04-012025-03-3105965639core:UnlistedNon-exchangeTraded2024-04-012025-03-3105965639core:MoreThanFiveYears2024-04-012025-03-3105965639core:Non-currentFinancialInstruments2025-03-3105965639core:Non-currentFinancialInstruments2024-03-3105965639dpl:CostSales2024-04-012025-03-3105965639dpl:DistributionCosts2024-04-012025-03-3105965639core:LandBuildings2024-04-012025-03-3105965639core:PlantMachinery2024-04-012025-03-3105965639core:Vehicles2024-04-012025-03-3105965639core:FurnitureFittings2024-04-012025-03-3105965639core:OfficeEquipment2024-04-012025-03-3105965639dpl:AdministrativeExpenses2024-04-012025-03-3105965639core:NetGoodwill2024-04-012025-03-3105965639core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105965639dpl:GroupUndertakings2024-04-012025-03-3105965639dpl:ParticipatingInterests2024-04-012025-03-3105965639dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3105965639core:ListedExchangeTraded2024-04-012025-03-3105965639dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3105965639core:UnlistedNon-exchangeTraded2024-04-012025-03-3105965639dpl:CostSales2023-04-012024-03-3105965639dpl:DistributionCosts2023-04-012024-03-3105965639core:LandBuildings2023-04-012024-03-3105965639core:PlantMachinery2023-04-012024-03-3105965639core:Vehicles2023-04-012024-03-3105965639core:FurnitureFittings2023-04-012024-03-3105965639core:OfficeEquipment2023-04-012024-03-3105965639dpl:AdministrativeExpenses2023-04-012024-03-3105965639core:NetGoodwill2023-04-012024-03-3105965639core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3105965639dpl:GroupUndertakings2023-04-012024-03-3105965639dpl:ParticipatingInterests2023-04-012024-03-3105965639dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3105965639core:ListedExchangeTraded2023-04-012024-03-3105965639dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3105965639core:UnlistedNon-exchangeTraded2023-04-012024-03-3105965639core:NetGoodwill2025-03-3105965639core:IntangibleAssetsOtherThanGoodwill2025-03-3105965639core:LandBuildings2025-03-3105965639core:PlantMachinery2025-03-3105965639core:Vehicles2025-03-3105965639core:FurnitureFittings2025-03-3105965639core:OfficeEquipment2025-03-3105965639core:AfterOneYear2025-03-3105965639core:WithinOneYear2025-03-3105965639core:ListedExchangeTraded2025-03-3105965639core:UnlistedNon-exchangeTraded2025-03-3105965639core:ShareCapital2025-03-3105965639core:SharePremium2025-03-3105965639core:RevaluationReserve2025-03-3105965639core:OtherReservesSubtotal2025-03-3105965639core:RetainedEarningsAccumulatedLosses2025-03-3105965639core:NetGoodwill2024-03-3105965639core:IntangibleAssetsOtherThanGoodwill2024-03-3105965639core:LandBuildings2024-03-3105965639core:PlantMachinery2024-03-3105965639core:Vehicles2024-03-3105965639core:FurnitureFittings2024-03-3105965639core:OfficeEquipment2024-03-3105965639core:AfterOneYear2024-03-3105965639core:WithinOneYear2024-03-3105965639core:ListedExchangeTraded2024-03-3105965639core:UnlistedNon-exchangeTraded2024-03-3105965639core:ShareCapital2024-03-3105965639core:SharePremium2024-03-3105965639core:RevaluationReserve2024-03-3105965639core:OtherReservesSubtotal2024-03-3105965639core:RetainedEarningsAccumulatedLosses2024-03-3105965639core:NetGoodwill2023-03-3105965639core:IntangibleAssetsOtherThanGoodwill2023-03-3105965639core:LandBuildings2023-03-3105965639core:PlantMachinery2023-03-3105965639core:Vehicles2023-03-3105965639core:FurnitureFittings2023-03-3105965639core:OfficeEquipment2023-03-3105965639core:AfterOneYear2023-03-3105965639core:WithinOneYear2023-03-3105965639core:ListedExchangeTraded2023-03-3105965639core:UnlistedNon-exchangeTraded2023-03-3105965639core:ShareCapital2023-03-3105965639core:SharePremium2023-03-3105965639core:RevaluationReserve2023-03-3105965639core:OtherReservesSubtotal2023-03-3105965639core:RetainedEarningsAccumulatedLosses2023-03-3105965639core:AfterOneYear2024-04-012025-03-3105965639core:WithinOneYear2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105965639core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3105965639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3105965639core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3105965639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3105965639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3105965639bus:Director12024-04-012025-03-3105965639bus:Director22024-04-012025-03-3105965639bus:Director32024-04-012025-03-3105965639core:FurnitureFittingsToolsEquipment2024-03-3105965639core:FurnitureFittingsToolsEquipment2024-04-012025-03-3105965639core:FurnitureFittingsToolsEquipment2025-03-31

J.A. CRESCENT DENTAL CARE LIMITED

Registered Number
05965639
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

J.A. CRESCENT DENTAL CARE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr Mohammed Jahangir Ali
Mrs Natalie Ali
Jaz Ali Ltd

Registered Address

3 The Crescent
Dunston
Gateshead
NE11 9SJ

Registered Number

05965639 (England and Wales)
J.A. CRESCENT DENTAL CARE LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets374,13190,366
74,13190,366
Current assets
Stocks48,0426,428
Debtors854,033739,007
Cash at bank and on hand150,456110,666
1,012,531856,101
Creditors amounts falling due within one year5(191,821)(149,357)
Net current assets (liabilities)820,710706,744
Total assets less current liabilities894,841797,110
Provisions for liabilities6(18,533)(22,592)
Net assets876,308774,518
Capital and reserves
Called up share capital400400
Profit and loss account875,908774,118
Shareholders' funds876,308774,518
The financial statements were approved and authorised for issue by the Board of Directors on 22 December 2025, and are signed on its behalf by:
Dr Mohammed Jahangir Ali
Director
Registered Company No. 05965639
J.A. CRESCENT DENTAL CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year-end date is recognised by reference to the stage of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year1011
3.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 24139,403159,03419,29013,724331,451
Additions-3269805,3446,650
At 31 March 25139,403159,36020,27019,068338,101
Depreciation and impairment
At 01 April 24117,974106,66210,6415,808241,085
Charge for year7,76710,5401,9262,65222,885
At 31 March 25125,741117,20212,5678,460263,970
Net book value
At 31 March 2513,66242,1587,70310,60874,131
At 31 March 2421,42952,3728,6497,91690,366
4.Stocks

2025

2024

££
Other stocks8,0426,428
Total8,0426,428
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables41,50229,972
Taxation and social security75,79848,177
Other creditors41,44257,312
Accrued liabilities and deferred income33,07913,896
Total191,821149,357
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)18,53322,592
Total18,53322,592
7.Related party transactions
During the year the directors made available a loan to the company of £41,441 (2024: £57,312). Interest has been charged on this balance at the UK market rate. The loan is repayable on demand.